Table 1.

Clinical features, laboratory outcomes, treatment strategies, and outcomes of the 18 patients.

Patients	Age (years)/gender	Incubation (d)	Skin Rash	Enlarged lymph nodes	Highest temperature (°C)	Eosinophil count/Percent (*109/L/%)	ALT (U/L)	AST (U/L)	Diagnostic score	Outcome
1(2)	4/F	14	Yes	Yes	40.0	2.94	>500	>400	6a	Improved
2(3)	43/F	21	Yes	Yes	38.5	1.05	108	66	7a	Improved
3(4)	61/M	14	Yes	No	38.8	5.90	21	28	5a	Improved
4(4)	67/F	24	Yes	Yes	38.5	1.13	102	69	7a	Improved
5(4)	83/M	28	Yes	No	37.2	3.25	104	90	6a	Improved
6(4)	77/M	14	Yes	No	38.5	1.30	105	36	5a	Improved
7(4)	59/M	21	Yes	No	38.6	1.10	117	59	5a	Improved
8(4)	60/M	20	Yes	Yes	38.9	0.80	240	161	7a	Improved
9(4)	39/F	8	Yes	Yes	40.0	2.60	13	22	6a	Improved
10(4)	48/M	28	Yes	No	38.0	13.1%	1,242	881	5a	Improved
11(5)	74/F	9	Yes	No	38.5	36%	64	90	5b	Dead
12(6)	61/F	31	Yes	-	39.2	2.68	27	-	7a	Improved
13(6)	29/M	18	Yes	-	39.7	1.64	30	-	4a	Improved
14(6)	54/F	4	Yes	-	39.8	0.90	39	-	4a	Improved
15(6)	12/M	14	Yes	-	40.0	0.79	1,099	-	6a	Improved
16(6)	69/F	18	Yes	-	38.3	1.47	52	-	5a	Improved
17(6)	53/M	25	Yes	-	39.8	2.60	212	-	8a	Improved
18case	60/F	29	Yes	Yes	39.5	1.33	114	68	8a	Improved

^aRegiSCAR scoring system (Total score < 2 excluded, 2–3: possible, 4–5: probable, and >5: definite) (14).

^bJapanese Consensus Group Criteria (five criteria: atypical; seven criteria: typical) (13).